PCRX vs COLL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

PCRX

58.6
AI Score
VS
PCRX Wins

COLL

56.2
AI Score

Investment Advisor Scores

PCRX

59score
Recommendation
STRONG BUY

COLL

56score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PCRX COLL Winner
Forward P/E 8.726 3.8775 COLL
PEG Ratio 11.2121 0 Tie
Revenue Growth 6.2% 6.3% COLL
Earnings Growth -30.0% -46.6% PCRX
Tradestie Score 58.6/100 56.2/100 PCRX
Profit Margin 2.0% 5.9% COLL
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY HOLD PCRX

Relative Price Performance (Last 90 Days)

PCRX 1M: -4.9% · 3M: +5.1% COLL 1M: -23.8% · 3M: -21.2%

Current Technical Phase

PCRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 49.5 · Price: $24.67

COLL

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.9%), weak momentum, RSI 32

RSI (14): 32.0 · Price: $27.11

Fundamentals Snapshot

Metric PCRX COLL
Market Cap
Forward P/E 6.9 4.0
Trailing P/E 67.7 21.7
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.8% 0.9%
Operating Margin 0.1% 0.1%
EPS 0.36 1.27
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PCRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.